Product Spotlight

Patient Resources

In The News

Xoft® is the only FDA cleared electronic brachytherapy (eBx®) system that has been used to treat 10,000 plus non-melanoma skin
cancer patients & is supported by positive
4-year clinical data.

iCAD is committed to providing advanced cancer detection and treatment options for unparalleled care.

Learn more about CAD technology and Xoft® eBx® for your cancer treatment.

  • SKIN eBx®

    Surgery is not the only option.

    Learn more about eBx® for non-melanoma skin cancer treatment.


    “I came in with cancer, went to sleep, and when I woke up, I was completely done with my breast cancer treatment.”

    –Marianne, IORT Patient  Learn more.

  • GYN eBx®

    Learn more about GYN eBx® for your gynecological cancer treatment.

  • Computer-Aided Detection (CAD)

    iCAD technology helps physicians and patients in the fight against the most prevalent cancers: breast, colorectal,  and prostate. Learn more about CAD.

iCAD Launches National Educational Program to Increase Awareness of the Effective Use of Electronic Brachytherapy for the Treatment of Nonmelanoma Skin Cancer
Read More

iCAD to Present at the 6th Annual Craig-Hallum Apha Select Conference
Read More

iCAD Announces Appointment of Two Vice Presidents to Lead Cancer Detection Sales and Marketing Teams
Read More


View All News & Events »

Connect with iCAD

© 2014, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo and Never Stop Looking is a trademark of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.